This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $680,850
Discovering new high-risk ovarian cancer predisposing genes through targeted genetic analyses of a Canadian founder population
CIHR · 2017 · Nominated PI
- $99,060
Interrogating large available biobank data from defined cohorts to investigate a moderately infrequent, functionally aberrant and potentially actionable proposed new cancer predisposing alleles.
CIHR · 2017 · Nominated PI
- $6,000
Determining the efficacy, acceptability and safety of cold-coagulation treatment against cervical precancerious lesions in low-income countries
CIHR · 2012 · Supervisor
Discovering new high-risk ovarian cancer predisposing genes through targeted genetic analyses of a Canadian founder population
Principal investigators: Tonin, Patricia N
Keywords: Biobanks; Cancer Predispositon; Cancer Prevention; Dna Sequencing; Exome Sequencing; Founder Populations; Germline Mutations,; Hereditary Cancer,; Mutation Screening; Ovarian Cancer
Interrogating large available biobank data from defined cohorts to investigate a moderately infrequent, functionally aberrant and potentially actionable proposed new cancer predisposing alleles.
Principal investigators: Tonin, Patricia N
Keywords: Biobanks; Biomarkers; Breast Cancer Risk; Cancer Prevention; Dna Repair Genes; Founder Population; French Canadians; Hereditary Factors; Medical Genetics; Ovarian Cancer Risk
Determining the efficacy, acceptability and safety of cold-coagulation treatment against cervical precancerious lesions in low-income countries
Principal investigators: Dolman, Lena
Keywords: Cervical Cancer; Genetics; Low-Resource Countries; Mortality Rates; Ovarian Cancer; Precancerious Cervical Lesions; Prognosis
Estimating the contribution of BRCA2 to hereditary ovarian cancers in the French Canadian population of Quebec.
Principal investigators: Dolman, Lena
Keywords: Brca2; Cancer Genetics; Cancer Susceptibility; Founder Effects; French Canadian Population; Ovarian Cancer; Recurrent Mutations
Elucidating the tumor suppressor genes involved in reprogramming an ovarian cancer cell line model modified by chromosome 3 transfer
Principal investigators: Tonin, Patricia N
Keywords: Chromosome/Gene Transfer; Gene Expression Arrays; Mutation Analysis; Ovarian Cancer; Positonal Cloning; Tumor Suppressor Genes
An integrated functional and genomics approach at elucidating the chromosome 3 genes important in ovarian cancer
Principal investigators: Tonin, Patricia N
Keywords: Chromosome/Gene Transfer; Gene Expression Arrays; Mutation Analysis; Ovarian Cancer; Positonal Cloning; Tumor Suppressor Genes
Molecular Genetic Analyses of Chromosome 3p Genes in Epithelial Ovarian Cancer
Principal investigators: Birch, Ashley H
Keywords: Affymetrix Microarray; Chromosome 3; Genotyping Snp Array; Loss Of Heterozygosity; Low Malignant Potential; Malignant Ovarian Cancer; Response To Therapy; Tumour Suppressor Genes; Tumourigenicity Assays; Wnt5a
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.